Based on our 2009 Pharmacor Hepatitis C Virus report, Decision Resources is offering an exclusive analyst call entitled The Battle for Market Supremacy in Hepatitis C Virus: Which Drug Will Emerge on Top – Telaprevir or Boceprevir? Because this analyst call features major report findings, it is ONLY available to purchasers of this report.


 

This analyst call was held on November 19, 2009. Contact us to learn how you can purchase this report and access a recorded playback of this event.

Click here to view the invite.